Kitty M Kolding, CEO and Co-Founder, Raisonance Group of Companies
- Kitty is the CEO and co-founder of Raisonance Group of Companies.
- Starting at the age of 22 years with the founding of her first company, she has proven herself to be a successful CEO with an eye for global markets.
Podcast
Overview
Kitty M. Kolding, the visionary CEO and Co-Founder of Raisonance Group shares her remarkable journey in revolutionising healthcare diagnostics through artificial intelligence (AI) and the unique use of sound. From tackling the challenges of COVID-19 to venturing into the complex realm of tuberculosis, Kolding’s entrepreneurial spirit and commitment to impactful innovation shine through. Join us as we delve into her insights, the transformative power of technology, and the unyielding belief in moonshot endeavours.
About Kitty M Kolding
- Kitty is the CEO and co-founder of Raisonance Group of Companies.
- Starting at the age of 22 years with the founding of her first company, she has proven herself to be a successful CEO with an eye for global markets.
- She has been quoted across major media outlets, such as The New York Times, The Wall Street Journal, USA Today, and Fox News.
10:59- And what are you doing now?
- I run a company called Raisonance. And we’re an artificial intelligence machine learning company focused on healthcare.
- The idea originated during the pandemic in March 2020 when the National Science Foundation had an emergency call out for innovative technologies related to COVID-19.
- The company is committed to changing the way diagnostic services are delivered and experienced, aiming for non-invasive, scalable, and technology-oriented solutions.
16:00- Can you explain the advantages of using machine learning to classify audio markers in coughs for detecting certain health conditions, highlighting its non-invasiveness, cost-effectiveness, and scalability?
- Its non-invasiveness, demonstrated by a mobile app that processes coughs without physical tests, ensures user comfort and eliminates the need for manufacturing or consumables, making it cost-effective.
- The system’s scalability, processing 20,000 tests per second, enables rapid deployment during health crises.
- Additionally, the automatic reporting to public health authorities ensures near real-time response, making it a powerful, accessible, and impactful tool for global health challenges.
RESOURCES:
Learn more about Kitty M Kolding: LinkedIn
Enjoyed this podcast?
If you learned new insights about Healthcare Diagnostics with AI and Sound, subscribe and share it with friends!
Love to give us 5 stars? ⭐⭐⭐⭐⭐ If you do, we’d love a review from you. Help us reach more people to keep them in the know as we talk to leaders, high achievers, and thought leaders from diverse backgrounds and nationalities. Excellence can come from anywhere; stay in the know, and hear from emergent high achievers and gurus.
Stay updated with what’s shaping the world today through the latest The Brand Called You Podcast episode. Follow us on iTunes, Spotify, and Anchor.fm.
You can find us at:
Website: www.tbcy.in
Instagram: http://bit.ly/3HO7N06
Facebook:http://bit.ly/3YzJOaD
Twitter: http://bit.ly/3wMBOXK
LinkedIn: https://www.linkedin.com/company/tbcy/
YouTube: http://bit.ly/3jmBqfq
Chingari: https://chingari.io/tbcypodcast
Josh: http://bit.ly/3WWP0nB
Thanks for listening!
Profile
- Kitty is the CEO and co-founder of Raisonance Group of Companies.
- Starting at the age of 22 years with the founding of her first company, she has proven herself to be a successful CEO with an eye for global markets.
- She has been quoted across major media outlets, such as The New York Times, The Wall Street Journal, USA Today, and Fox News.
